miR-23a can target Atrogin-1 and MuRF1 and inhibit their translation, and the ectopic expression of miR-23a protects muscles from atrophy in vitro and in vivo, indicating that miR-23a is a critical regulator in muscular atrophy. This evidence concerns the gene TRIM63 and muscular atrophy.